Evidence map›Paper›PMID 25851810›Full record

ArticleNature communications2015

The E3 ubiquitin ligase Trim7 mediates c-Jun/AP-1 activation by Ras signalling.

Atanu Chakraborty, Markus E Diefenbacher, Anastasia Mylona, Olivier Kassel, Axel Behrens

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Current research of the Notch pathway in hepatocellular carcinoma.European journal of medical research · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Atanu ChakrabortyMammalian Genetics Laboratory, London Research Institute, Cancer Research UK, Lincoln's Inn Fields Laboratories, London WC2A 3LY, UK.
Markus E DiefenbacherMammalian Genetics Laboratory, London Research Institute, Cancer Research UK, Lincoln's Inn Fields Laboratories, London WC2A 3LY, UK.
Anastasia MylonaSignal Transduction and Transcription Laboratory, London Research Institute, Cancer Research UK, Lincoln's Inn Fields Laboratories, London WC2A 3LY, UK.
Olivier KasselKarlsruhe Institute of Technology (KIT), Institute of Toxicology and Genetics (ITG), Building 304, Room 208A, Hermann-von-Helmholtz-Platz 1, Eggenstein-Leopoldshafen D-76344, Germany.
Axel Behrens1] Mammalian Genetics Laboratory, London Research Institute, Cancer Research UK, Lincoln's Inn Fields Laboratories, London WC2A 3LY, UK [2] School of Medicine, King's College London, Guy's Campus, London SE1 1UL, UK.
The Honourable Society of Lincoln's Inn · GBCancer Research UK · GBKarlsruhe Institute of Technology · DEKing's College London · GB

Funding

Cancer Research UK 15679Cancer Research UK A3588Worldwide Cancer Research 12-0149
6 · The paper itself

Abstract

The c-Jun/AP-1 transcription factor controls key cellular behaviours, including proliferation and apoptosis, in response to JNK and Ras/MAPK signalling. While the JNK pathway has been well characterized, the mechanism of activation by Ras was elusive. Here we identify the uncharacterized ubiquitin ligase Trim7 as a critical component of AP-1 activation via Ras. We found that MSK1 directly phosphorylates Trim7 in response to direct activation by the Ras-Raf-MEK-ERK pathway, and this modification stimulates Trim7 E3 ubiquitin ligase activity. Trim7 mediates Lys63-linked ubiquitination of the AP-1 co-activator RACO-1, leading to RACO-1 protein stabilization. Consequently, Trim7 depletion reduces RACO-1 levels and AP-1-dependent gene expression. Moreover, transgenic overexpression of Trim7 increases lung tumour burden in a Ras-driven cancer model, and knockdown of Trim7 in established xenografts reduces tumour growth. Thus, phosphorylation-ubiquitination crosstalk between MSK1, Trim7 and RACO-1 completes the long sought-after mechanism linking growth factor signalling and AP-1 activation.

Indexed as

AnimalsApoptosisCarrier ProteinsCell Line, TumorCell ProliferationHEK293 CellsHeLa CellsHumansLung NeoplasmsMAP Kinase Signaling SystemMiceMice, TransgenicNeoplasm TransplantationPhosphorylationProto-Oncogene Proteins c-junProto-Oncogene Proteins c-mycCarrier Proteinsmitogen and stress-activated protein kinase 1MYC protein, humanProto-Oncogene Proteins c-junProto-Oncogene Proteins c-mycraf Kinasesras ProteinsRibosomal Protein S6 Kinases, 90-kDaRNF187 protein, humanTrans-ActivatorsTranscription Factor AP-1TRIM7 protein, humanTripartite Motif ProteinsUbiquitin-Protein Ligases

Identifiers

PMID25851810
PMCPMC4395875
OpenAlexW2042295402

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.